Wave Life Sciences Ltd. — Director's Dealing 2015

Nov 11, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2015-11-10

Reporting Person: Tanaka Masaharu (Director, 10% Owner)
Reporting Person: Kagoshima Shinsangyo Sousei Investment Limited Partnership (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	2990777	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred Shares	$		Ordinary Shares (161663)		Direct

Footnotes

F1: Shares held by Kagoshima Shinsangyo Sousei Investment Limited Partnership ("KSS"). Masaharu Tanaka, a director of the Issuer, is a director of KSS and may be deemed to beneficially own the reported securities. Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), Mr. Tanaka disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The filing of this Form 3 shall not be construed as an admission that Mr. Tanaka is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the reported securities.

F2: Shares held by KSS. Mr. Tanaka may be deemed to beneficially own the reported securities. Pursuant to Rule 16a-1 under the Act, Mr. Tanaka disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interests therein. The filing of this Form 3 shall not be construed as an admission that Mr. Tanaka is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the reported securities. These shares are convertible into ordinary shares on a one-for-one basis at any time at the election fo the holder and have no expiration date.